Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 33%
Buy 56%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare is expected to continue its growth trajectory as it operates a large network of hospitals and outpatient facilities, which have been performing well due to strong pricing and expense management. Additionally, the company's Conifer segment provides a stable source of revenue through its revenue cycle management solutions. The company's solid financials, including a strong cash flow and manageable leverage, also add to the positive outlook for the stock. However, like any healthcare organization, Tenet Healthcare is exposed to risks such as regulatory and legislative changes, potential shifts in payor mix, and natural disasters. The recent 1Q26 results were solid, with a 3% EBITDA beat driven by acuity gains and expense management, and management expressed confidence in future trends. With a target multiple that balances current sentiment and the company's positive attributes, along with potential upside in upcoming quarters, the stock is poised for long-term success.

Bears say

Tenet Healthcare is facing significant headwinds in the current healthcare environment, including uncertainty around healthcare reform and policy changes, expiration of ACA subsidies, and potential economic downturns impacting elective caseloads. While the company has maintained its 2026 guidance, risks to achieving these projections include potential declines in high-acuity volumes and margin pressures, as well as challenges to generating free cash flow for capital deployment. Despite strong performance in their Ambulatory Care Segment, the company's exposure to HIX volumes and potential uninsured patients presents a significant financial risk for their future revenue.

Tenet Healthcare (THC) has been analyzed by 18 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 18 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $267.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $267.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.